Man Group’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Sell
142,271
-86,370
-38% -$14.9M 0.05% 430
2025
Q4
$41.8M Sell
228,641
-59,267
-21% -$8.27M 0.08% 279
2025
Q3
$35M Sell
287,908
-237,161
-45% -$26.7M 0.07% 338
2025
Q2
$54.8M Buy
525,069
+11,848
+2% +$1.25M 0.12% 218
2025
Q1
$59.9M Buy
513,221
+349,833
+214% +$39.9M 0.18% 150
2024
Q4
$13.8M Buy
+163,388
New +$15M 0.04% 597
2023
Q1
Sell
-116,492
Closed -$8.99M 2075
2022
Q4
$8.99M Buy
+116,492
New +$6.96M 0.03% 616
2021
Q3
Sell
-7,994
Closed -$539K 1896
2021
Q2
$539K Sell
7,994
-33,907
-81% -$2.03M ﹤0.01% 1540
2021
Q1
$2.37M Buy
41,901
+1,395
+3% +$98.1K 0.01% 1039
2020
Q4
$3.3M Sell
40,506
-2,304
-5% -$172K 0.01% 998
2020
Q3
$3.05M Buy
42,810
+28,383
+197% +$2.21M 0.01% 1041
2020
Q2
$1.19M Buy
+14,427
New +$1.11M 0.01% 1225

Other funds holding AXSM